Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide for Patients With Relapsed Primary Mediastinal Nonseminomatous Germ Cell Tumors: Benefit From Chemotherapy, Surgery, or Both?

被引：3
|
作者：
Einhorn, Lawrence H. [1 ,2 ]
Abonour, Rafat [1 ]
Kesler, Kenneth A.
机构：
[1] Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA
[2] Indiana Univ Sch Med, Lance Armstrong Fdn Chair Oncol, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 35期
关键词：
EXPERIENCE; POSTCHEMOTHERAPY;
D O I：
10.1200/JCO.2010.30.4626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E739 / E739
页数：1
相关论文
共 50 条
  • [21] Phase II-study of sequential High-Dose-Chemotherapy with Paclitaxel, Ifosfamide, Carboplatin, Etoposide (P-ICE) in patients with relapsed or refractory germ cell tumors (GCT)
    Cygon, F.
    Meinert, F.
    Hammad, K.
    Kegel, T.
    Steinbach, F.
    Seseke, F.
    Schmoll, H. -J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 10 - 11
  • [22] Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide(P-ICE) in patients with relapsed or refractory germ cell tumors (GCT).
    Kegel, Thomas
    Cygon, Franziska
    Meinert, Fabian Maximilian
    Hannmad, Khaled
    Steinbach, Frank
    Seseke, Florian
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] SALVAGE CHEMOTHERAPY OF NONSEMINOMATOUS GERM-CELL TUMORS - PHASE-II TRIAL OF AN ETOPOSIDE, IFOSFAMIDE AND HIGH-DOSE CISPLATIN (VLHP) COMBINATION
    RIBRAG, V
    DROZ, JP
    BOULEUC, C
    THEODORE, C
    GHOSN, M
    PICO, JL
    AZAB, M
    OSTRONOFF, M
    HAYAT, M
    PRESSE MEDICALE, 1990, 19 (27): : 1263 - 1266
  • [24] Taxol, ifosfamide, and cisplatin (TIP) followed by high-dose chemotherapy with carboplatin, etoposide and thiotepa (HD-CET) in germ-cell cancer
    Rick, O
    Beyer, J
    Bokemeyer, C
    Metzner, B
    Casper, J
    Wandt, H
    Hartmann, F
    Schmoll, HJ
    Kanz, L
    Huhn, D
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1999, 23 : S192 - S192
  • [25] High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study
    S Kleiner
    A Kirsch
    I Schwaner
    D Kingreen
    N Schwella
    D Huhn
    W Siegert
    Bone Marrow Transplantation, 1997, 20 : 953 - 959
  • [26] High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study
    Kleiner, S
    Kirsch, A
    Schwaner, I
    Kingreen, D
    Schwella, N
    Huhn, D
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1997, 20 (11) : 953 - 959
  • [27] High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases
    Kalra, Maitri
    Adra, Nabil
    Hanna, Nasser
    Abonour, Rafat
    Einhorn, Lawrence H.
    CANCER, 2020, 126 (06) : 1202 - 1207
  • [28] Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors
    Mardiak, J
    Fuchsberger, P
    Lakota, J
    Sálek, T
    Sycová-Milá, Z
    Drahokoupilová, M
    Baláz, M
    Koza, I
    NEOPLASMA, 2000, 47 (04) : 239 - 243
  • [29] Salvage chemotherapy with high dose carboplatin plus etoposide (HDCE) and peripheral blood stem cell transplant (PBSCT) in patients with germ cell tumors (GCT).
    Einhorn, L. H.
    Williams, S.
    Abonour, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 228S - 228S
  • [30] Patterns of relapse after primary or salvage high-dose chemotherapy in patients with advanced nonseminomatous germ cell tumors
    Oechsle, K.
    Lorch, A.
    Honecker, F. U.
    Kollmannsberger, C.
    Hartmann, J. T.
    Boehlke, I.
    Beyer, J.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345